Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MATCh-GDM: Individualized Treatment for Gestational Diabetes
NCT03029702Phase 4Completed
- Start
- Feb 2018
- Primary completion
- Aug 2023
- Modality
- Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of human insulin, glibenclamide, metformin in gestational diabetes mellitus (GDM). Started Feb 2018; status: completed.
02
Drugs
human insulinglibenclamidemetformin
03
Conditions
gestational diabetes mellitus (GDM)
Beyond the preview
Go deeper on NCT03029702.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03029702.